StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Relypsa (RLYP) Gains Ahead of Binary Event
May 25, 2016 11:04 AM
Relypsa (NASDAQ: RLYP) will be on watch today ahead of tomorrow's PFUDA for AstraZeneca (NYSE: AZN) competing drug ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Rumors
Trader Talk
Next Articles
BTIG Remains Bullish on Relypsa (RLYP) Following 'Surprise' CRL for AstaZeneca's (AZN) ZS-9
May 27, 2016 8:50 AM
AstraZeneca's (AZN) Phase III FALCON Trial of Fulvestrant vs. Anastrozole Met Primary Endpoint
May 27, 2016 7:08 AM
AstraZeneca's CRL on ZS-9 Reduces Near Term Commercial Risk for Veltassa and Relypsa (RLYP) - Wedbush
May 27, 2016 6:34 AM
Relypsa (RLYP) Surges Higher After AstraZeneca's ZS-9 Receives CRL from FDA
May 27, 2016 6:18 AM
Relypsa (RLYP) Ticks Higher Ahead of FDA on ZS-9
May 26, 2016 4:38 PM
Relypsa (RLYP) Surges as Street's Biggest Bear Upgrades
May 23, 2016 10:40 AM
Morgan Stanley Upgrades Relypsa, Inc. (RLYP) to Equalweight
May 23, 2016 6:42 AM
.jpg)
